A Phase 1 Randomized, Double-blinded, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVsVΔG-LASV-GPC Vaccine in Adults in Good General Health

We are looking for healthy volunteers to participate in an investigational Lassa Fever vaccine study. The purpose of the study is to see if the vaccine is safe and produces a good immune response.

More information regarding the study can be found: https://clinicaltrials.gov/ct2/show/NCT04794218

International AIDS Vaccine Initiative
Principal Investigator(s)
Dr. Elissa Malkin, DO, MPH/Medicine & Microbiology, Immunology and Tropical Medicine
Contact Phone Number